Optibrium receives further investment from Kester Capital

Optibrium receives further investment from Kester Capital   Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology. CAMBRIDGE, UK, 21 June 2022 – Optibrium™, a developer of...